TriangleIpilimumab and Nivolumab (NCT07075120)
Ipilimumab and Nivolumab trial for Hepatocellular Carcinoma (HCC) (NCT07075120). This is a short film with English narration. The transcript is on this page, and the written brief is separate.
Lo que dice el vídeo
Lee la transcripción
This trial is for locally advanced hepatocellular carcinoma, a liver cancer, in adults.
The idea: combine two immunotherapy drugs, ipilimumab and nivolumab, with targeted radiation before surgery. Patients first receive the drugs for nine weeks. Scans then show whether the tumor can be removed. If not, immunotherapy continues with radiation in three to five treatments, and surgery follows once removal is possible.
This pilot phase 1 study plans 15 patients and measures feasibility. At the University of Hawaii in Honolulu, Jared Acoba leads it.
Public record; not medical advice.
¿Ya estás en un ensayo?
Se convierte en un proyecto que hay que manejar: citas, estudios de imagen, análisis, efectos secundarios y papeleo. Triangle lo mantiene organizado en un solo lugar, para ti o para quien te ayuda.
Organizar mi ensayoPrueba gratuita de 7 días, después $9 al mes. Cancela cuando quieras.
Cómo funcionan estos ensayos: qué es de verdad la fase 1 · preguntas frecuentes No es evidencia clínica.